Pfizer acquires stem cell therapies assets of Axordia
Nov 23, 2009 (Datamonitor Financial Deals Tracker via COMTEX) --
Company: Pfizer Ltd (PZRLF)
Pfizer, Ltd., a pharmaceutical company, has acquired certain assets related to stem cell therapies from Axordia Limited, a developer of stem cell therapies for human diseases, for a cash consideration of $0.75 million. Both the companies are based in the UK.
Deal Value (US$ Million) 0.75 Deal Type Acquisition Sub-Category Asset Purchase Deal Status Completed: 2009-11-23
Deal Participants
Target (Company) Axordia Limited - Stem Cell Therapies Assets Acquirer (Company) Pfizer, Ltd. (UK) Vendor (Company) Axordia Limited
Copyright (C) 2010 Datamonitor Financial Deals Tracker. All rights reserved
News Provided by COMTEX
Company: Pfizer Ltd (PZRLF)
Related terms: acquisition, pharmaceuticals
